MANSC1 and neoplasm: Moreover, linear regression model analysis of tumor stage indicated high plasma levels of Fms-related tyrosine kinase 4 (FLT4), MANSC domain-containing protein 1 (MANSC1), and lysophosphatidic acid (LPA) phosphatase type 6 (ACP6), that could be used as potential prognostic biomarkers for advanced CRC.